Audrick Gibert

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Venues

Clinical pharmacokinetics

Fundamental & clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Audrick Gibert, Julien Lanoiselée, Isabelle Gouin-Thibault, Adeline Pontis, Kasra Azarnoush, Andranik Petrosyan, Nathalie Grand, Serge Molliex, Jérome Morel, Laurent Gergelé, Sophie Hodin, Valérie Bin, Robin Chaux, Xavier Delavenne, Edouard Ollier
Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass. Clinical pharmacokinetics (2024)
Audrick Gibert, Julien Lanoiselée, Isabelle Gouin-Thibault, Adeline Pontis, Kasra Azarnoush, Andranik Petrosyan, Nathalie Grand, Serge Molliex, Jérome Morel, Laurent Gergelé, Sophie Hodin, Valérie Bin, Robin Chaux, Xavier Delavenne, Edouard Ollier
Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass. Clinical pharmacokinetics 63 (2) (2024)
Audrick Gibert, Julien Lanoiselée, Isabelle Gouin-Thibault, Adeline Pontis, Kasra Azarnoush, Andranik Petrosyan, Nathalie Grand, Serge Molliex, Jérome Morel, Laurent Gergelé, Sophie Hodin, Valérie Bin, Robin Chaux, Xavier Delavenne, Edouard Ollier
Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass. Clinical pharmacokinetics 63 (2) (2024)
Audrick Gibert, Julien Lanoiselée, Isabelle Gouin-Thibault, Adeline Pontis, Kasra Azarnoush, Andranik Petrosyan, Nathalie Grand, Serge Molliex, Jérome Morel, Laurent Gergelé, Sophie Hodin, Valérie Bin, Robin Chaux, Xavier Delavenne, Edouard Ollier
Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass. Clinical pharmacokinetics 63 (2) (2024)
Audrick Gibert, Julien Lanoiselée, Luc Janisset, Gilles Pernod, Edouard Ollier, Xavier Delavenne
Development of a Bayesian estimation tool to determine the optimal duration of apixaban discontinuation before a high-bleeding risk procedure. Fundamental & clinical pharmacology 36 (5) (2022)

Audrick Gibert.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Audrick Gibert